Utah-based Intermountain Healthcare launches study to detect breast cancer through blood test
In a three-year program, researchers will compare samples from patients with and without the disease to identify signature tumor DNA in hopes of improving diagnosis techniques.
(Photo courtesy of Intermountain Healthcare) Utah-based Intermountain Healthcare announced on Monday it hoped to develop a blood test to detect breast cancer, in hopes of detecting the disease in patients earlier. Picture are (l-r) Lincoln Nadauld, executive director of the Intermountain Healthcare Precision Genomics Program; Brett Parkinson, imaging and medical director of the Intermountain Medical Center Breast Care Center; and Linda Warner, a breast cancer survivor.